Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 743

1.

Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe.

Hamamatsu K, Fujimoto H, Fujita N, Murakami T, Kimura H, Saji H, Inagaki N.

Nucl Med Biol. 2018 Jun 8;64-65:22-27. doi: 10.1016/j.nucmedbio.2018.06.002. [Epub ahead of print]

PMID:
30015092
2.

Solid-phase extraction treatment is required for measurement of active GLP-1 by ELISA kit affected by heterophilic antibodies.

Hasegawa T, Komagata M, Hamasaki A, Harada N, Seino Y, Inagaki N.

J Diabetes Investig. 2018 Jul 11. doi: 10.1111/jdi.12896. [Epub ahead of print]

3.

Live imaging analysis of the growth plate in a murine long bone explanted culture system.

Hirota K, Yasoda A, Kanai Y, Ueda Y, Yamauchi I, Yamashita T, Sakane Y, Fujii T, Inagaki N.

Sci Rep. 2018 Jul 9;8(1):10332. doi: 10.1038/s41598-018-28742-x.

4.

Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study.

Nishimura A, Harashima SI, Hosoda K, Inagaki N.

Diabetes Ther. 2018 Jun 12. doi: 10.1007/s13300-018-0457-6. [Epub ahead of print]

PMID:
29949015
5.

Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients.

Inagaki N, Harashima SI, Iijima H.

Expert Opin Pharmacother. 2018 Jun;19(8):895-908. doi: 10.1080/14656566.2018.1473378. Epub 2018 May 25.

PMID:
29799286
6.

Immune suppression of food allergy by maternal IgG in murine models.

Yamashita H, Hayashi T, Saneyasu K, Matsuhara H, Matsui T, Tanaka H, Inagaki N.

Allergol Int. 2018 Apr 30. pii: S1323-8930(18)30043-1. doi: 10.1016/j.alit.2018.04.001. [Epub ahead of print]

7.

Transcriptional factor pancreatic duodenal homeobox-1 (Pdx1) is involved in age-related GIP hypersecretion in mice.

Ikeguchi E, Harada N, Kanemaru Y, Sankoda A, Yamane S, Iwasaki K, Imajo M, Murata Y, Suzuki K, Joo E, Inagaki N.

Am J Physiol Gastrointest Liver Physiol. 2018 May 3. doi: 10.1152/ajpgi.00054.2018. [Epub ahead of print]

PMID:
29723041
8.

Characteristics of the Japanese Diet Described in Epidemiologic Publications: A Qualitative Systematic Review.

Suzuki N, Goto Y, Ota H, Kito K, Mano F, Joo E, Ikeda K, Inagaki N, Nakayama T.

J Nutr Sci Vitaminol (Tokyo). 2018;64(2):129-137. doi: 10.3177/jnsv.64.129.

9.

Dietary habits associated with reduced insulin resistance: The Nagahama study.

Ikeda K, Sato T, Nakayama T, Tanaka D, Nagashima K, Mano F, Joo E, Fujimoto S, Takahashi Y, Kosugi S, Sekine A, Tabara Y, Matsuda F, Inagaki N; Nagahama Study Group.

Diabetes Res Clin Pract. 2018 Jul;141:26-34. doi: 10.1016/j.diabres.2018.04.006. Epub 2018 Apr 19.

PMID:
29679632
10.

Oxygen management in mechanically ventilated patients: A multicenter prospective observational study.

Egi M, Kataoka J, Ito T, Nishida O, Yasuda H, Okamaoto H, Shimoyama A, Izawa M, Matsumoto S, Furushima N, Yamashita S, Takada K, Ohtsuka M, Fujisaki N, Shime N, Inagaki N, Taira Y, Yatabe T, Nitta K, Yokoyama T, Kushimoto S, Tokunaga K, Doi M, Masuda T, Miki Y, Matsuda K, Asaga T, Hazama K, Matsuyama H, Nishimura M, Mizobuchi S; ; ABOVE investigators.

J Crit Care. 2018 Aug;46:1-5. doi: 10.1016/j.jcrc.2018.03.024. Epub 2018 Mar 21.

PMID:
29605719
11.

Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.

Fujii T, Hirota K, Yasoda A, Takizawa A, Morozumi N, Nakamura R, Yotsumoto T, Kondo E, Yamashita Y, Sakane Y, Kanai Y, Ueda Y, Yamauchi I, Yamanaka S, Nakao K, Kuwahara K, Jindo T, Furuya M, Mashimo T, Inagaki N, Serikawa T, Nakao K.

PLoS One. 2018 Mar 22;13(3):e0194812. doi: 10.1371/journal.pone.0194812. eCollection 2018.

12.

A Novel p.L145Q Mutation in the HNF1B Gene in a Case of Maturity-onset Diabetes of the Young Type 5 (MODY5).

Kato T, Tanaka D, Muro S, Jambaljav B, Mori E, Yonemitsu S, Oki S, Inagaki N.

Intern Med. 2018 Jul 15;57(14):2035-2039. doi: 10.2169/internalmedicine.9692-17. Epub 2018 Feb 28.

13.

Grip and slip of L1-CAM on adhesive substrates direct growth cone haptotaxis.

Abe K, Katsuno H, Toriyama M, Baba K, Mori T, Hakoshima T, Kanemura Y, Watanabe R, Inagaki N.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2764-2769. doi: 10.1073/pnas.1711667115. Epub 2018 Feb 26.

14.

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study.

Harashima SI, Inagaki N, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Watanabe Y.

Diabetes Obes Metab. 2018 Jul;20(7):1770-1775. doi: 10.1111/dom.13267. Epub 2018 Mar 24.

15.

Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.

Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Suzuki T, Tsuiki M, Naruse M.

Clin Endocrinol (Oxf). 2018 May;88(5):645-651. doi: 10.1111/cen.13582. Epub 2018 Mar 13.

PMID:
29464741
16.

Cross-cultural comparison of predictors for self-care behaviors in patients with type 2 diabetes.

Ikeda K, Fujimoto S, Morling B, Ayano-Takahara S, Harashima SI, Uchida Y, Inagaki N.

J Diabetes Investig. 2018 Feb 17. doi: 10.1111/jdi.12822. [Epub ahead of print]

17.

Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.

Maekawa R, Ogata H, Murase M, Harada N, Suzuki K, Joo E, Sankoda A, Iida A, Izumoto T, Tsunekawa S, Hamada Y, Oiso Y, Inagaki N, Arima H, Hayashi Y, Seino Y.

Am J Physiol Endocrinol Metab. 2018 Jun 1;314(6):E572-E583. doi: 10.1152/ajpendo.00352.2017. Epub 2018 Feb 6.

PMID:
29406782
18.

Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report.

Yoshiji S, Shibue K, Fujii T, Usui T, Hirota K, Taura D, Inoue M, Sone M, Yasoda A, Inagaki N.

Medicine (Baltimore). 2017 Dec;96(51):e9091. doi: 10.1097/MD.0000000000009091.

19.

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group.

Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.

PMID:
29358460
20.

Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors.

Ohno Y, Sone M, Taura D, Yamasaki T, Kojima K, Honda-Kohmo K, Fukuda Y, Matsuo K, Fujii T, Yasoda A, Ogawa O, Inagaki N.

Hypertens Res. 2018 Mar;41(3):165-175. doi: 10.1038/s41440-017-0002-4. Epub 2018 Jan 18.

PMID:
29348428
21.

Intra- and inter-subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co-transporter 2 inhibitor canagliflozin.

Polidori D, Iijima H, Goda M, Maruyama N, Inagaki N, Crawford PA.

Diabetes Obes Metab. 2018 May;20(5):1321-1326. doi: 10.1111/dom.13224. Epub 2018 Feb 14.

22.

β-cell-specific overexpression of adiponectin receptor 1 does not improve diabetes mellitus in Akita mice.

Choi J, Kobayashi H, Okuda H, Harada KH, Takeda M, Fujimoto H, Yamane S, Tanaka D, Youssefian S, Inagaki N, Koizumi A.

PLoS One. 2018 Jan 5;13(1):e0190863. doi: 10.1371/journal.pone.0190863. eCollection 2018.

23.

Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans.

Yamauchi I, Sakane Y, Yamashita T, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Fujii T, Taura D, Sone M, Yasoda A, Inagaki N.

Endocrine. 2018 Feb;59(2):353-363. doi: 10.1007/s12020-017-1495-y. Epub 2017 Dec 22.

PMID:
29274063
24.

The Effect of Novel Glucose Monitoring System (Flash Glucose Monitoring) on Mental Well-being and Treatment Satisfaction in Japanese People with Diabetes.

Mitsuishi S, Nishimura R, Harashima SI, Kawamura T, Tsujino D, Koide K, Nishimura A, Utsunomiya K, Inagaki N, Atsumi Y.

Adv Ther. 2018 Jan;35(1):72-80. doi: 10.1007/s12325-017-0649-x. Epub 2017 Dec 22.

PMID:
29273859
25.

Evaluation of 18F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging.

Kimura H, Ogawa Y, Fujimoto H, Mukai E, Kawashima H, Arimitsu K, Toyoda K, Fujita N, Yagi Y, Hamamatsu K, Murakami T, Murakami A, Ono M, Nakamoto Y, Togashi K, Inagaki N, Saji H.

Bioorg Med Chem. 2018 Jan 15;26(2):463-469. doi: 10.1016/j.bmc.2017.12.007. Epub 2017 Dec 5.

PMID:
29273416
26.

A new buckwheat dihydroflavonol 4-reductase (DFR), with a unique substrate binding structure, has altered substrate specificity.

Katsu K, Suzuki R, Tsuchiya W, Inagaki N, Yamazaki T, Hisano T, Yasui Y, Komori T, Koshio M, Kubota S, Walker AR, Furukawa K, Matsui K.

BMC Plant Biol. 2017 Dec 11;17(1):239. doi: 10.1186/s12870-017-1200-6.

27.

Whole-exome sequencing in a Japanese family with highly aggregated diabetes identifies a candidate susceptibility mutation in ADAMTSL3.

Jambaljav B, Tanaka D, Nagashima K, Harashima SI, Harada N, Harada T, Fujiwara Y, Wang Y, Liu Y, Tabara Y, Matsuda F, Koizumi A, Inagaki N.

Diabetes Res Clin Pract. 2018 Jan;135:143-149. doi: 10.1016/j.diabres.2017.11.012. Epub 2017 Nov 21.

PMID:
29162515
28.

Histamine-releasing factor enhances food allergy.

Ando T, Kashiwakura JI, Itoh-Nagato N, Yamashita H, Baba M, Kawakami Y, Tsai SH, Inagaki N, Takeda K, Iwata T, Shimojo N, Fujisawa T, Nagao M, Matsumoto K, Kawakami Y, Kawakami T.

J Clin Invest. 2017 Dec 1;127(12):4541-4553. doi: 10.1172/JCI96525. Epub 2017 Nov 13.

29.

Significance of dopamine D1 receptor signalling for steroidogenic differentiation of human induced pluripotent stem cells.

Matsuo K, Sone M, Honda-Kohmo K, Toyohara T, Sonoyama T, Taura D, Kojima K, Fukuda Y, Ohno Y, Inoue M, Ohta A, Osafune K, Nakao K, Inagaki N.

Sci Rep. 2017 Nov 9;7(1):15120. doi: 10.1038/s41598-017-15485-4.

30.

Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima SI, Kaku K, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Iijima H.

Diabetes Obes Metab. 2018 Apr;20(4):812-820. doi: 10.1111/dom.13152. Epub 2017 Dec 5.

31.

Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism.

Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):900-908. doi: 10.1210/jc.2017-01774.

PMID:
29092077
32.

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Ikeda A, Ikeda K, Takai A, Takahashi K, Ueda Y, Marusawa H, Seno H, Inagaki N, Kokuryu H.

Digestion. 2017 Oct 30;96(4):228-230. doi: 10.1159/000484237. [Epub ahead of print]

PMID:
29084399
33.

Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.

Inagaki N, Chou HS, Tsukiyama S, Washio T, Shiosakai K, Nakatsuka Y, Taguchi T.

BMJ Open Diabetes Res Care. 2017 Sep 29;5(1):e000424. doi: 10.1136/bmjdrc-2017-000424. eCollection 2017.

34.

Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.

Shibata W, Sohara M, Wu R, Kobayashi K, Yagi S, Yaguchi K, Iizuka Y, Iwasa M, Nakahata H, Yamaguchi T, Matsumoto H, Okada M, Taniguchi K, Hayashi A, Inazawa S, Inagaki N, Sasaki T, Koh R, Kinoshita H, Nishio M, Ogashiwa T, Ookawara A, Miyajima E, Oba M, Ohge H, Maeda S, Kimura H, Kunisaki R.

Inflamm Bowel Dis. 2017 Nov;23(11):2042-2047. doi: 10.1097/MIB.0000000000001230.

PMID:
29045261
35.

Regulation of glucagon-like peptide-1 sensitivity by gut microbiota dysbiosis.

Yamane S, Inagaki N.

J Diabetes Investig. 2018 Mar;9(2):262-264. doi: 10.1111/jdi.12762. Epub 2017 Dec 1.

36.

Effects of three major amino acids found in Japanese broth on glucose metabolism and gastric emptying.

Mano F, Ikeda K, Joo E, Yamane S, Harada N, Inagaki N.

Nutrition. 2018 Feb;46:153-158.e1. doi: 10.1016/j.nut.2017.08.007. Epub 2017 Aug 10.

PMID:
29031770
37.

Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance.

Patel KA, Kettunen J, Laakso M, Stančáková A, Laver TW, Colclough K, Johnson MB, Abramowicz M, Groop L, Miettinen PJ, Shepherd MH, Flanagan SE, Ellard S, Inagaki N, Hattersley AT, Tuomi T, Cnop M, Weedon MN.

Nat Commun. 2017 Oct 12;8(1):888. doi: 10.1038/s41467-017-00895-9.

38.

Insulinoma with a History of Epilepsy: Still a Possible Misleading Factor in the Early Diagnosis of Insulinoma.

Murakami T, Yamashita T, Yabe D, Masui T, Teramoto Y, Minamiguchi S, Hirota K, Ogura M, Nagashima K, Inagaki N.

Intern Med. 2017 Dec 1;56(23):3199-3204. doi: 10.2169/internalmedicine.8932-17. Epub 2017 Oct 11.

39.

Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.

Kanai Y, Yasoda A, Mori KP, Watanabe-Takano H, Nagai-Okatani C, Yamashita Y, Hirota K, Ueda Y, Yamauchi I, Kondo E, Yamanaka S, Sakane Y, Nakao K, Fujii T, Yokoi H, Minamino N, Mukoyama M, Mochizuki N, Inagaki N.

J Clin Invest. 2017 Nov 1;127(11):4136-4147. doi: 10.1172/JCI94912. Epub 2017 Oct 9.

40.

Beta-cell replacement strategies for diabetes.

Kieffer TJ, Woltjen K, Osafune K, Yabe D, Inagaki N.

J Diabetes Investig. 2017 Oct 6. doi: 10.1111/jdi.12758. [Epub ahead of print] Review.

41.

Vitamin D deficiency exacerbates sensitization and allergic diarrhea in a murine food allergy model.

Matsui T, Yamashita H, Saneyasu KI, Tanaka H, Ito K, Inagaki N.

Allergol Int. 2018 Apr;67(2):289-291. doi: 10.1016/j.alit.2017.08.010. Epub 2017 Sep 19. No abstract available.

42.

Synthesis and biological evaluation of an 111In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic β-cells.

Kimura H, Fujita N, Kanbe K, Matsuda H, Watanabe H, Arimitsu K, Fujimoto H, Hamamatsu K, Yagi Y, Ono M, Inagaki N, Saji H.

Bioorg Med Chem. 2017 Oct 15;25(20):5772-5778. doi: 10.1016/j.bmc.2017.09.005. Epub 2017 Sep 7.

PMID:
28927802
43.

High prevalence of vitamin B-12 insufficiency in patients with Crohn's disease.

Ao M, Tsuji H, Shide K, Kosaka Y, Noda A, Inagaki N, Nakase H, Tanaka K.

Asia Pac J Clin Nutr. 2017;26(6):1076-1081. doi: 10.6133/apjcn.022017.13.

44.

Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.

Maekawa R, Seino Y, Ogata H, Murase M, Iida A, Hosokawa K, Joo E, Harada N, Tsunekawa S, Hamada Y, Oiso Y, Inagaki N, Hayashi Y, Arima H.

J Nutr Biochem. 2017 Nov;49:71-79. doi: 10.1016/j.jnutbio.2017.07.010. Epub 2017 Jul 25.

45.
46.

Localization of photoperiod responsive circadian oscillators in the mouse suprachiasmatic nucleus.

Yoshikawa T, Inagaki NF, Takagi S, Kuroda S, Yamasaki M, Watanabe M, Honma S, Honma KI.

Sci Rep. 2017 Aug 15;7(1):8210. doi: 10.1038/s41598-017-08186-5.

47.

Lipopolysaccharide inhibits hepatic gluconeogenesis in rats: The role of immune cells.

Tanaka H, Nishikawa Y, Fukushima T, Taniguchi A, Fujita Y, Tsuda K, Inagaki N, Hosokawa M.

J Diabetes Investig. 2017 Aug 14. doi: 10.1111/jdi.12729. [Epub ahead of print]

48.

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Gouda M, Iijima H, Watanabe Y.

Diabetes Obes Metab. 2018 Feb;20(2):453-457. doi: 10.1111/dom.13079. Epub 2017 Sep 15.

49.

Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Seko Y, Sumida Y, Sasaki K, Itoh Y, Iijima H, Hashimoto T, Ishii S, Inagaki N.

J Gastroenterol. 2018 Jan;53(1):140-151. doi: 10.1007/s00535-017-1364-8. Epub 2017 Jul 1.

PMID:
28669071
50.

Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.

Ida S, Morino K, Sekine O, Ohashi N, Kume S, Chano T, Iwasaki K, Harada N, Inagaki N, Ugi S, Maegawa H.

Diabetologia. 2017 Sep;60(9):1761-1769. doi: 10.1007/s00125-017-4327-y. Epub 2017 Jun 22.

PMID:
28642969

Supplemental Content

Loading ...
Support Center